Investor profile
- Type
- Venture Capital
- Headquarters
- Palo Alto
- Aliases
- Frazier Life Sciences, Frazier Life Sciences (FLS)
- Tracked investments
- 1
- Regions
- North America, Greater China
- Stages
- Seed, Series A, Series B, Series C, Crossover, Public
- Sectors
- Biotechnology, Healthtech
Recent related events
- Crystalys Therapeutics raises $130.0MJul 23, 2026